InnoCare Announces Clearance of Clinical Trial of BCL2 Inhibitor ICP-248 by U.S. FDA
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a commercial-stage biotech company, announced today that the…
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a commercial-stage biotech company, announced today that the…
Sharing Research Results and Promoting the Sustainable Growth of the Industry SHANGHAI, CHINA - Media…
The Rosefield Energy Tech Awards, which recognizes innovation and leadership in the lubricants and fuels…
HO CHI MINH CITY, VIETNAM - Media OutReach Newswire - 16 January 2024 - TUMI,…
TAITUNG, Taiwan--(BUSINESS WIRE)--On Jan. 15, Taiwan’s southeastern county of Taitung held its first tourism presentation…
SINGAPORE - Media OutReach Newswire - 16 January 2024 - As urbanization and economic levels…
A Leap into the Future: Real Axe's Advanced AI Ushers in a New Era of…
SINGAPORE - Media OutReach Newswire - 16 January 2024 - Cyber incidents such as ransomware…
Infobip is equal leader across three of 12 categories with an overall score of 88%…
New commercialisation agreement builds on existing partnership with Zuellig Pharma SINGAPORE - Media OutReach Newswire…